Please assess the completion status of the following clinical trial:

Trial Title: Cycling in Parkinson's Disease

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Idiopathic Parkinson's Disease~* Hoehn and Yahr Stages II - III.~* Ages 30-80 years~* Medical Clearance~* Ability to understand and the willingness to sign a written informed consent.~Exclusion Criteria:~* MOCA: (Montreal Cognition Scale) : rating of less than 24, indicative of cognitive dysfunction~* Changes in Parkinson's medications within the two weeks prior to starting the study~* Anticipated change in Parkinson Disease medications during the course of the study~* Uncontrolled orthostasis~* Symptomatic coronary artery disease~* Fracture of lower limb within 6 months prior to study onset or significant lower limb orthopedic diagnosis that would limit cycling~* Other significant neurologic diagnoses including multiple sclerosis or vestibular disease~* Acute illness~* Physical therapy within the month prior to study entry~* Subjects already participating in a forced exercise or high intensity exercise program~* Any medical condition that the physician investigator determined would compromise safety.

- Gender: ALL
- Minimum Age: 30 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Forced exercise cycling (Type: ACTIVE_COMPARATOR): Cycling exercise at approximately 90 rpm
- Self-selected pace cycling (Type: ACTIVE_COMPARATOR): Cycling at self selected rate, with same aerobic level as forced cycling group

Based on this trial design, predict the completion outcome and termination type (if applicable).